Affymax (OTCMKTS:AFFY) Share Price Passes Above Two Hundred Day Moving Average – Time to Sell?

Affymax Inc. (OTCMKTS:AFFY – Get Free Report) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.0010. Affymax shares last traded at $0.0010, with a volume of 500 shares changing hands.

Affymax Price Performance

Get Affymax alerts:

Affymax Company Profile

(Get Free Report)

Affymax, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for the treatment of rare and underserved diseases. The company leverages its proprietary TransCon® drug delivery platform to create prodrugs that offer sustained, predictable release of active pharmaceutical ingredients. Affymax’s research efforts concentrate on endocrinology and nephrology indications, seeking to address conditions that currently have limited treatment options.

Among its lead product candidates, Affymax is advancing TransCon® PTH for the treatment of hypoparathyroidism and TransCon® Growth Hormone (TransCon® GH) for pediatric growth hormone deficiency.

See Also

• Five stocks we like better than Affymax
• AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target
• Micron’s $250 Billion Bet Could Reshape the AI Memory Race
• Rocket Lab’s Stock Drop Comes With a Bullish Twist
• Amazon’s New Debt Deal Puts Its AI Spending Story on Trial

Receive News & Ratings for Affymax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affymax and related companies with MarketBeat.com's FREE daily email newsletter.